Through These Veins
Impossible d'ajouter les articles
Désolé, nous ne pouvons pas ajouter cet article car votre panier a atteint sa capacité maximale.
Impossible d'ajouter le titre au panier.
Veuillez réessayer plus tard
Impossible d'ajouter le titre à la liste d'envies.
Veuillez réessayer plus tard
«Retirer de la liste d'envies» a échoué.
Veuillez réessayer plus tard
Échec de « Suivre le podcast »
Échec de «Ne plus suivre le podcast»
0,99 €/mois pendant 3 mois + 15 € de crédit Audible
Renouvellement automatique à 6,99 €/mois après 3 mois. Annulation mensuelle possible.
L'offre prend fin le 28 décembre 2026.
Acheter pour 14,73 €
-
Lu par :
-
Anne Marie Ruff
-
De :
-
Anne Marie Ruff
À propos de ce titre
In the coffee-growing highlands of Ethiopia, an Italian scientist on a plant-collecting expedition discovers a local medicine man dispensing an apparent cure for AIDS. As the medicine man’s teenage daughter reveals the plants behind the cure, their lives become irrevocably intertwined.
Through These Veins weaves together the dramatically different worlds of traditional healing, U.S. government funded AIDS research, and the pharmaceutical industry in an intensely personal, fast-paced tale of scientific intrigue and love, with both devastating and hopeful effect.
©2011 Anne Marie Ruff (P)2013 Cherry Hill Publishing
adbl_web_anon_alc_button_suppression_t1
Avis de la critique
"Enthralling. Through These Veins doesn't just call plants by their names; it sings their praises. There is no better case for conservation than this vivid account of how our well-being is so intertwined with the secret lives of plants." (Calestous Juma, director of science, technology, and globalization project at Harvard University’s Kennedy School of Government, and former executive secretary of the UN Convention on Biological Diversity)
"A real pleasure. Very dramatic with a wide range of vivid descriptions and an important reminder of the relationship between science and nature." (Warren Olney, host of Public Radio International’s To The Point)
Aucune critique pour le moment